Get 20% lifetime commission for referring investors to digrin.com
here.
MiMedx Group, Inc. (MDXG) Financials
MDXG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 281.0 million | 65.0 million |
| March 31, 2026 | 308.7 million | 65.7 million |
| Dec. 31, 2025 | 342.7 million | 86.1 million |
| Sept. 30, 2025 | 319.0 million | 80.0 million |
MDXG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -10.7 million | 903000 |
| March 31, 2026 | 1.3 million | -1.7 million |
| Dec. 31, 2025 | 24.6 million | 2.5 million |
| Sept. 30, 2025 | 25.4 million | 4.9 million |
MDXG Net Income
No data available :(
MDXG Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 135.8 million | - | - |
| March 31, 2026 | 159.8 million | 16.1 million | - |
| Dec. 31, 2025 | 166.1 million | 16.5 million | 3.2 million |
| Sept. 30, 2025 | 142.1 million | 16.8 million | - |
MDXG Shares Outstanding
MDXG Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 707000 | 2.8 million | 59.8 million | 46.4 million |
| March 31, 2026 | 570000 | 4.1 million | 53.2 million | 43.9 million |
| Dec. 31, 2025 | 377000 | 4.8 million | 73.1 million | - |
| Sept. 30, 2025 | 3.9 million | 3.7 million | 69.0 million | 53.7 million |
MDXG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 64.4 million | 20.0 million |
| March 31, 2026 | 59.0 million | 17.4 million |
| Dec. 31, 2025 | 118.1 million | 19.1 million |
| Sept. 30, 2025 | 113.7 million | 18.7 million |
MDXG Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MDXG
Price: $4.19
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.04 USD
P/E Ratio: 106.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 621.7 million